The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
/ genetics
Blood Proteins
/ metabolism
Carcinoma, Squamous Cell
/ genetics
Cyclin-Dependent Kinase Inhibitor p16
/ metabolism
Female
Galectins
/ metabolism
Gene Expression Regulation, Neoplastic
/ genetics
Humans
Immunohistochemistry
India
Middle Aged
Papillomaviridae
Papillomavirus Infections
/ complications
Predictive Value of Tests
Uterine Cervical Neoplasms
/ genetics
Uterine Cervical Dysplasia
/ genetics
SCC cervix
dysplasia
galectin-3
p16
Journal
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
ISSN: 1364-6893
Titre abrégé: J Obstet Gynaecol
Pays: England
ID NLM: 8309140
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
pubmed:
20
10
2020
medline:
3
11
2021
entrez:
19
10
2020
Statut:
ppublish
Résumé
Cervical cancer is the most prevalent cancer among women in India. The main cause of cervical cancer is persistent human papilloma viral (HPV) infection. HPV inactivates the pRb tumour suppressor protein; thus p16 expression, which is controlled by a negative feedback mechanism, is relatively increased. Galectin-3 is directly and indirectly connected to cancer cell activity and contributes to oncogenesis, angiogenesis, cancer progression and metastasis. Thus, the aim of this study was to study the expression of p16 and galectin-3 in Cervical Intraepithelial Neoplasia (CIN) and Squamous Cell Carcinoma (SCC) and to correlate p16 and galectin-3 expression. On hundred and eighteen newly-diagnosed untreated cases of CIN and SCC of uterine cervix were included in the study. Expression of p16 and galectin 3 was more pronounced in invasive SCC and High-grade Intraepithelial Lesion (HSIL), as compared to Low-grade Intraepithelial Lesion (LSIL).Thus, it may be used in clinical setting to monitor cervical lesions and to predict their progression.Impact statement
Identifiants
pubmed: 33073644
doi: 10.1080/01443615.2020.1803235
doi:
Substances chimiques
Biomarkers, Tumor
0
Blood Proteins
0
Cyclin-Dependent Kinase Inhibitor p16
0
Galectins
0
LGALS3 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM